The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
© Fossey et al; licensee BioMed Central Ltd. 2011
Received: 21 December 2010
Accepted: 28 March 2011
Published: 28 March 2011
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|21 Dec 2010||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|11 Jan 2011||Reviewed||Reviewer Report - Gobinda Sarkar|
|21 Jan 2011||Reviewed||Reviewer Report - Hiroshi Masuno|
|24 Jan 2011||Reviewed||Reviewer Report - Douglas Thamm|
|3 Mar 2011||Author responded||Author comments - Cheryl London|
|Resubmission - Version 3|
|3 Mar 2011||Submitted||Manuscript version 3|
|8 Mar 2011||Reviewed||Reviewer Report - Gobinda Sarkar|
|9 Mar 2011||Reviewed||Reviewer Report - Hiroshi Masuno|
|22 Mar 2011||Author responded||Author comments - Cheryl London|
|Resubmission - Version 4|
|22 Mar 2011||Submitted||Manuscript version 4|
|28 Mar 2011||Editorially accepted|
|28 Mar 2011||Article published||10.1186/1471-2407-11-112|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.